Editas Medicine, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
34.36 |
13.83 |
15.38 |
9.00 |
9.00 |
10.85 |
| Przychód Δ r/r |
0.00% |
-59.75% |
11.22% |
-41.48% |
0.00% |
20.56% |
| Przychód (min) |
3.72 |
5.94 |
5.45 |
3.19 |
3.19 |
3.84 |
| Przychód (max) |
53.91 |
41.25 |
43.71 |
25.58 |
25.58 |
30.84 |
| EBITDA (średnia) |
-34.36 |
-13.83 |
-15.38 |
-9.00 |
-9.00 |
-10.85 |
| EBIT (średnia) |
-34.36 |
-13.83 |
-15.38 |
-9.00 |
-9.00 |
-10.85 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-220.71 |
-155.57 |
-126.06 |
-91.69 |
-91.40 |
-97.65 |
| Zysk netto % |
-642.38% |
-1124.99% |
-819.64% |
-1018.74% |
-1015.50% |
-900.00% |
| EPS (średnia) |
-2.70 |
-1.89 |
-1.08 |
-1.09 |
-1.11 |
-1.19 |
| Liczba analityków (Przychody) |
11 |
9 |
13 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
11 |
10 |
12 |
4 |
3 |
2 |
| symbol |
EDIT |
EDIT |
EDIT |
EDIT |
EDIT |
EDIT |